Overview
Title
To amend the Internal Revenue Code of 1986 to provide a refundable tax credit for non-directed living kidney donations.
ELI5 AI
The "End Kidney Deaths Act" is a new plan that gives people money back on their taxes if they donate a kidney to a stranger, hoping to help more people get the kidneys they need to stay healthy.
Summary AI
H.R. 2687, titled the "End Kidney Deaths Act," proposes changes to the Internal Revenue Code of 1986 to create a new tax credit for individuals who donate a kidney without knowing the recipient's identity. If enacted, donors could receive a $10,000 refundable tax credit for the year of donation and the next four years, totaling up to $50,000. The bill includes a provision to accelerate this credit in the case of the donor's death. This tax credit is designed to encourage more living kidney donations while avoiding conflicts with the National Organ Transplant Act, as the credit will not be considered payment for the organ.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
The proposed bill, known as the "End Kidney Deaths Act," is a piece of legislation aimed at addressing issues related to organ donation, particularly kidney donations. This legislation introduces a significant financial incentive for individuals who donate a kidney without knowing the recipient. The bill offers a refundable tax credit of $10,000 for the year of donation and the next four years, potentially totaling $50,000 if the donor passes away during this period. The bill specifies that this tax credit applies to donations made after December 31, 2026, and ceases on December 31, 2036. Notably, the bill also amends related legislation to ensure this tax credit is not considered a form of organ purchase, which is illegal under current U.S. law.
Summary of Significant Issues
One of the critical issues raised by this bill is the ethical implications of providing a substantial financial incentive for organ donation. Offering up to $50,000 could be seen as influencing individuals' motivation to donate, possibly leading them to make such decisions for financial gain rather than altruistic reasons. This could challenge ethical standards in medical practice, where consent should be informed and voluntary.
Another concern relates to the provision that accelerates the tax credit to reach a total of $50,000 in the event of the donor's death. The rationale here is unclear and could inadvertently encourage high-risk donations. Moreover, verifying whether a donation is truly "non-directed" might prove challenging, as the bill requires that donors do not know the identity of the recipient, yet does not detail a robust system for verifying compliance with this requirement.
Furthermore, the bill sets an expiration date on December 31, 2036, for the tax credit. This deadline raises questions about the policy's long-term viability and whether there will be provisions to reassess and potentially extend these incentives. The specific choice of this date seems arbitrary without an explicit rationale provided.
Broad Public Impact
The introduction of this tax credit could potentially increase the number of living kidney donations by reducing financial barriers for those considering donation. This could ease the shortage of available kidneys for transplantation, reduce wait times, and enhance outcomes for individuals suffering from renal failure. By framing the incentive as a tax credit rather than a direct payment, the bill attempts to navigate legal constraints while still motivating donors.
However, there is a risk that marketing kidney donation with financial incentives could diminish public trust in the organ donation system. Ethical concerns about commercialization of body parts may affect societal attitudes, potentially affecting individuals' willingness to participate in organ donation programs.
Impact on Specific Stakeholders
Recipients of kidney transplants stand to benefit from this legislation, as an increase in organ availability could lead to improved health outcomes and reduced time spent on waiting lists. Society at large might also benefit from reduced healthcare costs associated with managing chronic kidney disease.
Potential donors might find the financial incentive appealing, assisting them in covering expenses incurred during donation recovery. However, the promise of financial gain might disproportionately attract individuals from lower socio-economic backgrounds, raising ethical worries about exploitation and undue coercion.
Healthcare providers, including transplant coordinators and surgeons, would experience changes in demand and operational procedures due to an increased number of surgeries. They will need to address and manage ethical concerns related to the motivation behind donations.
In conclusion, while the End Kidney Deaths Act aims to bolster kidney donation rates through financial incentives, it brings with it a host of ethical, administrative, and pragmatic issues. Balancing these concerns with the need to address the organ shortage remains a complex challenge for lawmakers and society.
Financial Assessment
The proposed legislation, known as the "End Kidney Deaths Act," introduces a financial mechanism aimed at encouraging living kidney donations through the use of tax credits. This bill integrates financial references and incentives that require careful consideration due to their potential implications.
Summary of Financial Allocations
The bill proposes a $10,000 refundable tax credit for individuals who donate a kidney anonymously. This credit applies to the year the donation is made and extends through the subsequent four years, allowing donors to potentially claim up to $50,000 in total credits. This financial incentive is intended to motivate individuals to make non-directed kidney donations, thus increasing the number of available kidneys for transplant.
Relation to Identified Issues
Several issues arise from the financial references within the bill. Firstly, the acceleration clause of the credit, which offers the full amount of $50,000 in the event of the donor's death, raises ethical concerns. This provision, while intended to ensure that the donor or their estate receives the full benefit even if the donor passes away, might inadvertently encourage rushed or ill-considered donation decisions if individuals perceive a financial gain to their heirs in such a case.
The financial incentive, as substantial as $10,000 per year for five years, might influence individuals' decisions to donate. While financial incentives can boost donation rates, they also raise ethical questions about the motivations behind such life-altering decisions. The bill must balance promoting kidney donations while ensuring decisions are made based on personal convictions rather than financial gain alone.
The termination date for this tax credit is set at December 31, 2036. This specific cutoff might imply that the bill's authors view it as a temporary measure, potentially a trial to assess its effectiveness. However, without clear guidance or provisions for what will happen post-2036, there may be uncertainty about the future of these credits, possibly affecting individuals considering donation around that time.
Lastly, the enforcement and verification of the requirement that donors do not know the identity of the recipient could pose practical challenges. Ensuring compliance with the stipulation for anonymity is crucial; otherwise, the financial incentives could be misappropriated.
In conclusion, while the tax credit introduced by the "End Kidney Deaths Act" presents a promising approach to increasing kidney donations, the financial aspects of the bill introduce ethical and logistical challenges that warrant careful consideration and oversight.
Issues
The acceleration of the $50,000 credit in the event of the donor's death, covered in Section 2(c)(1), could incentivize overly hasty donations and poses ethical concerns about encouraging donations in risky circumstances.
The bill provides a $10,000 tax credit across five years for non-directed living kidney donations as described in Section 2(a). This financial incentive raises ethical concerns about potentially influencing individuals' decisions to donate.
The provision, detailed in Section 2(d), sets a termination date for the credit on December 31, 2036. This may limit the long-term impact of the bill and suggest the need for future legislative action to extend or reassess the necessity of these credits.
The requirement that donors must not know the identity of the recipient may present verification and compliance challenges, as stated in Section 2(b)(2). This raises potential difficulties in proving or verifying the non-directed status of donations.
The complexity of the tax-related and legal language throughout Section 2 could make understanding the provisions challenging for the average taxpayer, limiting accessibility to potential eligible donors.
There is no explanation in Section 2(d) for the chosen expiration date of the tax credit, nor provisions for extending or reassessing the need after this date, which makes the rationale for this cutoff unclear.
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of the bill states that the law shall be known as the “End Kidney Deaths Act.”
2. Credit for non-directed living kidney donations Read Opens in new tab
Summary AI
The bill section introduces a tax credit of $10,000 for individuals who donate a kidney without knowing the recipient, applicable for the year of donation and the next four years. It also specifies that if the donor dies, the total credit can increase up to $50,000. The tax credit applies only to donations made after December 31, 2026, and will end on December 31, 2036, without being considered as payment for the organ.
Money References
- “(a) In general.—In the case of an individual who makes a qualified non-directed living kidney donation during any taxable year, there shall be allowed as a credit against the tax imposed by this subtitle an amount equal to $10,000 for such taxable year and each of the 4 succeeding taxable years.
- “(c) Special rules.— “(1) ACCELERATION OF CREDIT IN CASE OF DEATH.—In the case of the death of any individual during a taxable year for which a credit is allowed under subsection (a) to such individual, the amount of such credit for such taxable year shall be equal to the excess of $50,000 over the aggregate amount of credits allowed to such individual under this section for all prior taxable years.
36C. Credit for non-directed living kidney donations Read Opens in new tab
Summary AI
The section provides a tax credit of $10,000 for individuals who donate a kidney through a qualified non-directed living donation, meaning they don't know the recipient, for the year of donation and the following four years. If the donor dies, the credit for that year is adjusted to ensure a total of $50,000 in credits, and no credits will be available for donations made after December 31, 2036.
Money References
- (a) In general.—In the case of an individual who makes a qualified non-directed living kidney donation during any taxable year, there shall be allowed as a credit against the tax imposed by this subtitle an amount equal to $10,000 for such taxable year and each of the 4 succeeding taxable years.
- (b) Qualified non-Directed living kidney donation.—For purposes of this section, the term “qualified non-directed living kidney donation” means, with respect to any individual, the donation of a kidney of such individual for the purpose of transplanting such kidney into another individual if— (1) the removal of kidney from such individual is during the life of such individual, and (2) such individual does not know (at the time of such removal) the identity of— (A) the individual into whom such kidney is to be transplanted, or (B) any other individual into whom any organ will be transplanted in connection with the donation of such kidney. (c) Special rules.— (1) ACCELERATION OF CREDIT IN CASE OF DEATH.—In the case of the death of any individual during a taxable year for which a credit is allowed under subsection (a) to such individual, the amount of such credit for such taxable year shall be equal to the excess of $50,000 over the aggregate amount of credits allowed to such individual under this section for all prior taxable years.